How to Help Your Patients Find Velphoro in Stock: A Provider's Guide

If your dialysis patients are calling your office unable to fill their Velphoro (sucroferric oxyhydroxide) prescriptions, you're not alone. Across the country, nephrology practices and dialysis care teams are spending significant time on access issues that — with the right systems in place — can be resolved efficiently. This guide gives you a clear workflow for helping patients get their Velphoro, reducing administrative burden on your staff.

Step 1: Identify the Patient's Insurance and Access Category

The first question to answer is: how should this patient be getting Velphoro? The 2025 ESRD PPS change created distinct pathways depending on coverage type.

• Medicare ESRD (fee-for-service): Since January 1, 2025, included in the PPS bundle. The dialysis organization provides Velphoro. If the patient isn't receiving it, the issue is with the dialysis center's formulary or administrative setup — not a pharmacy problem.

• Medicare Advantage or Commercial Insurance (primary): Needs a written prescription, prior authorization, and specialty/retail pharmacy dispensing. Your office will need to manage the PA process.

• Medicare-pending (new dialysis patient): Fresenius Medical Care may supply up to 90 days of Velphoro at no cost while Medicare eligibility is being processed. Contact Access Solutions: fax to 1-866-496-8638.

• Uninsured: Patient must apply for manufacturer PAP or consider a lower-cost alternative like generic sevelamer as a bridge.

Step 2: For Pharmacy-Dependent Patients, Streamline Your PA Workflow

Most commercial insurers and Medicare Part D plans require prior authorization for Velphoro. Having a streamlined PA process in your office can prevent delays of 3-5 business days that leave patients without medication. Here's what works:

1. Build a PA template. Create a pre-populated PA letter that includes: CKD diagnosis with ICD-10 code (N18.6), serum phosphorus level (document ≥5.5 mg/dL), dialysis type, step therapy failure or contraindication documentation, and nephrologist attestation.

2. Use Velphoro Access Solutions. The manufacturer's Access Solutions team can initiate the PA on your behalf. Fax the completed Access Solutions form to 1-866-496-8638. This can significantly reduce your staff workload.

3. Document hypercalcemia clearly. If your patient has hypercalcemia or a history of vascular calcification, this is your strongest argument for bypassing calcium acetate step therapy. Include corrected calcium levels and trend data in the PA.

4. Document pill burden intolerance. For elderly patients, patients with dysphagia, or patients with documented adherence issues on higher pill-burden binders, document this explicitly. Velphoro's 1 tablet/meal advantage is a valid medical rationale for many payers.

Step 3: Direct Patients to the Right Pharmacy Channel

Once the PA is in place (or not required), make sure your patients know where to fill their prescription. Do not send patients to a standard retail chain — Velphoro is rarely stocked there.

• Velphoro Concierge Support: Your office can fax the prescription directly to ASPN Pharmacies at 888-431-3403. Medication is shipped to the patient's home. Call 888-222-5270 for questions.

• Specialty pharmacies: CVS Specialty, Walgreens Specialty, and Optum Specialty can order Velphoro. Send the prescription to the specialty division, not the retail counter.

• medfinder:[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop is a paid service that calls pharmacies near the patient to identify which ones can fill Velphoro and texts the results to the patient. It can be a useful resource to recommend to patients who are actively searching.

Step 4: Bridge with an Alternative If There Is a Delay

If there will be a delay in getting Velphoro — due to a pending PA, insurance issue, or specialty pharmacy processing time — prescribe a bridge phosphate binder immediately. Do not let your patient go without phosphate binding. Consider:

• Generic sevelamer carbonate (most accessible, can be filled at any retail pharmacy)

• Calcium acetate (inexpensive, immediate access — use cautiously per calcium/PTH status)

• Office samples of Velphoro (request samples from Fresenius Medical Care: fax 855-812-7818)

Key Drug Interaction Reminder for Prescribers

When prescribing Velphoro, be aware of the following clinically significant interactions:

• Levothyroxine: Must be taken at least 4 hours before Velphoro. Velphoro reduces levothyroxine GI absorption. Critical for patients with hypothyroidism.

• Doxycycline, alendronate: Take at least 1 hour before Velphoro.

• Erdafitinib: Avoid Velphoro during the first 21-day initial dosing period. Phosphate binders can mask FGFR inhibitor dose-adjustment signals.

For a complete patient-facing drug interaction summary, see our guide on Velphoro drug interactions.